Publications

Molecular design of a therapeutic LSD analogue with reduced hallucinogenic potential

 106
Molecular design of a therapeutic LSD analogue with reduced hallucinogenic potential

Tags:

Previous Article

Interplay between mesothelial and immune cells in the tumor microenvironment

Next Article

LSD analogue with potential for treating schizophrenia

Related Posts

Rethinking neurodegeneration through a co-proteinopathy lens

Rethinking neurodegeneration through a co-proteinopathy...

 50

Integrated computational approaches for advancing antimicrobial peptide development

Integrated computational approaches for advancing antim...

 102

Low-intensity pulsed ultrasound modulates disease progression in the SOD1G93A mouse model of amyotrophic lateral sclerosis

Low-intensity pulsed ultrasound modulates disease progr...

 77